Elegen is advancing the field of synthetic biology through innovative DNA synthesis technologies that achieve an industry-leading capacity of producing 7kb sequences in just seven business days with exceptional accuracy. The company operates at the intersection of biology, chemistry, and engineering, applying cutting-edge methods to eliminate significant hurdles in synthetic biology workflows for sectors such as pharmaceuticals, biotechnology, agricultural biotechnology, and biomanufacturing. Elegen's mission is to empower its clients to fully leverage programmable biology, enhancing their operational efficiencies and capabilities. The company's collaborative culture promotes integrity, mutual respect, and a shared commitment to excellence among its team of multidisciplinary experts. Working at Elegen offers the opportunity to contribute to transformative projects in a rapidly evolving environment, with a focus on driving innovation and making a tangible impact in the life sciences sector.